• The development of drugs and companion diagnostics requires the collection of rigorous and reliable chemical, pharmaceutical, and biological data. • Candidate gene association studies can identify ...
The concept of regulatory science is not a new one. The FDA Science Board’s 2007 Science and Mission at Risk report (FDA Science Board, 2007) describes regulatory science as a science-based ...
The authors explore and define common industry approaches and practices when applying GMPs in early development. The International Consortium on Innovation and Quality in Pharmaceutical Development ...
This executive summary focuses on dose-flexible manufacturing strategies and their role in drug development. Dose flexibility is increasingly important for early clinical studies, particularly in ...
The Evidencing Development summary is the principal means by which your progress on the Doctoral Development Programme (DDP) is monitored. The purpose of the summary is to provide a record of your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results